AcuPebble Ox100
FDA-cleared home sleep testing device for obstructive sleep apnea diagnosis
Device · HybridCompany source
Company profile
About Acurable
Acurable creates accurate and user-friendly wearable medical devices for at-home monitoring of sleep apnea, epilepsy, COPD, and asthma.
Company description Acurable official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Acurable?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Asthma
- COPD
- Epilepsy
- Obstructive Sleep Apnea (OSA)
- Sleep Apnea
Who it serves
- Health Systems
- Healthcare Providers
- Sleep Clinics
Deployment & integration
Hybrid deployment with recorded integration context.
Geographic context
MarketsEuropean Union · Spain · United Kingdom · United States
Company sourceOfficial website
Company milestones
Platform expansion
FDA clearance for AcuPebble Ox100 as Class II medical device. CE mark certification for class IIa medical device. Selected by NHS Innovation Accelerator as one of 12 innovations to scale across NHS England. Opened Spanish office in Seville (2018).
Partnerships
Recorded partners
- Imperial College London
- Microsoft ScaleUp
- NHS (UK National Health Service)
- NHS Innovation Accelerator
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
AcuPebble SA100
CE-marked automated sleep apnea diagnosis device for adults
Device · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Heart rate, respiratory rate and airflow variability differences between stable and exacerbating COPD patients.ERJ open research · Nov 1, 2025
Validation of Tracheal Sound-Based Respiratory Effort Monitoring for Obstructive Sleep Apnoea Diagnosis.Journal of clinical medicine · Jun 20, 2024
Acoustic Sensing as a Novel Wearable Approach for Cardiac Monitoring at the Wrist.Scientific reports · Dec 27, 2019
Clinical validation
Clinical-trial records
Pilot Study for the Application of Low Power External Bioelectronic Devices in the Diagnosis of Bronchial Asthma.NCT06836375 · Sponsor · NOT YET RECRUITING
Clinical Evaluation of a Paediatric Sleep Diagnosis TechnologyNCT04031950 · Sponsor · RECRUITING
Pulse Oximeter Accuracy During Stable Hypoxia PlateausNCT06460246 · Sponsor · COMPLETED
Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep ApnoeaNCT04028011 · Sponsor · UNKNOWN
The Use of Wearable Technology to Acquire Signals for COPD ResearchNCT04495062 · Sponsor · COMPLETED
AcuPebble to Remotely Monitor Patients With OSA on CPAP TherapyNCT06097949 · Sponsor · UNKNOWN
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
94% Positive Predictive Value
Sleep apnea detection vs ambulatory gold standard
98% Negative Predictive Value
Sleep apnea detection vs ambulatory gold standard
100% patient completion rate
Patients able to complete test without training
90% apnea detection agreement
Agreement with sleep specialist vs 12% for PSG software
100% detection rate
Moderate and severe sleep apnea cases
NHS National Hospital for Neurology and Neurosurgery
Clinical trial comparing AcuPebble to Polysomnography software for sleep apnea detection
90% apnea detection agreement with sleep specialist vs. 12% for Polysomnography software (7x more accurate); 100% detection of moderate and severe sleep apnea cases
NHS Innovation Accelerator
Selected as one of 12 innovations to be supported to scale across NHS England
Selected from competitive field for NHS-wide implementation support
NHS Royal Free Hospital
Clinical validation trial comparing AcuPebble to at-home multi-channel polygraphy for sleep apnea detection
94% PPV, 98% NPV accuracy; 100% of patients able to complete test without training
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Esther Rodriguez-Villegas
Founder and Professor
06 · Company updates
Updates from Acurable
Recent articles published on Acurable's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.